Theramex dans l'actualité
Solutions et produits de santé pour femmes
Tamtam a trouvé 20 articles récents sur Theramex.
- HRT maker censured by regulators for ‘systemic failures’ that risked patient safety
- Theramex exits self-regulatory body after ‘systemic’ compliance failures
- Individualisation of Menopausal Hormone Therapy and Its Impact on Long-term Health
- UK marketing watchdog slams Theramex for 'wholly unacceptable' compliance failings
- Major HRT supplier sanctioned after whistleblowers raise concerns over patient safety
- Theramex receives recommendation for YSELTY in Scotland
- Theramex’s Eladynos recommended by NICE for post-menopausal bone disease
- NICE supports Theramex’s Eladynos for post-menopause osteoporosis
- Pharma deal could reduce choice and lead to higher prices for HRT treatments
- Theramex
- Theramex enters into an exclusive licensing agreement with Radius Health Inc to commercialise ELADYNOS®
- Bedell Cristin advises on sale of Theramex by CVC
- Latham Advises on CVC’s Sale of Theramex to PAI Partners and Carlyle
- PE Today: CVC Exits Theramex, Estancia Invests in Financial Services
- Carlyle, PAI Agree to Buy CVC’s Women’s Health Business Theramex
- CVC Fund VI agrees exit of Theramex
- Carlyle, PAI Nearing $1.4 Billion Deal for CVC’s Theramex
- International Women's Day sees Theramex reinforce its commitment to women's health
- Theramex to market Prolia biosimilar in Europe and Australia
- Fred Hassan appointed chairman of Theramex
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Theramex ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires